In the pipeline: Galeterone lowers PSA in CRPC study: Commentary
Publication
, Other
Moul, JW
Published in: Oncology Report
May 1, 2012
Duke Scholars
Published In
Oncology Report
ISSN
1548-5323
Publication Date
May 1, 2012
Issue
MAY
Start / End Page
12
Related Subject Headings
- Oncology & Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Moul, J. W. (2012). In the pipeline: Galeterone lowers PSA in CRPC study: Commentary. Oncology Report.
Moul, J. W. “In the pipeline: Galeterone lowers PSA in CRPC study: Commentary.” Oncology Report, May 1, 2012.
Moul JW. In the pipeline: Galeterone lowers PSA in CRPC study: Commentary. Oncology Report. 2012. p. 12.
Moul, J. W. “In the pipeline: Galeterone lowers PSA in CRPC study: Commentary.” Oncology Report, no. MAY, 1 May 2012, p. 12.
Moul JW. In the pipeline: Galeterone lowers PSA in CRPC study: Commentary. Oncology Report. 2012. p. 12.
Published In
Oncology Report
ISSN
1548-5323
Publication Date
May 1, 2012
Issue
MAY
Start / End Page
12
Related Subject Headings
- Oncology & Carcinogenesis